Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mind Medicine Mindmed Inc (NQ: MNMD )

7.560 +0.470 (+6.63%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Mind Medicine Mindmed Inc

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
31 32 Next >
Psychedelic Stock Gainers And Losers From February 27, 2023
Via Benzinga
"Multi-Bagger" Portfolio Outperforming "Rags-To-Riches" Portfolio By 2-To-1 Margin YTD
Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022 but perhaps some will bounce back with 
Via Talk Markets
Of The 6 Largest Psychedelic Drug Stocks, Only One Has Not Advanced YTD
The most critical financial information on the health of a company is whether, or not, it has a Net Positive Operating Cash Flow; its Altman -Z Score; its Piotroski F-Score; and the percentage... 
Via Talk Markets
Only 2 Of 5 Cannabis Categories Have Advanced YTD
The 5 categories in the cannabis sector perform quite differently from each other but YTD the common trend is mostly downward. 
Via Talk Markets
Psychedelic Stock Gainers And Losers From February 24, 2023
Via Benzinga
Psychedelic Stock Gainers And Losers From February 23, 2023
Via Benzinga
Psychedelic Stock Gainers And Losers From February 22, 2023
Via Benzinga
Why Wag! Group Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 21, 2023
Via Benzinga
Psychedelic Stock Gainers And Losers From February 20, 2023
Via Benzinga
"Multi-Bagger" Portfolio Outperforming "Rags-To-Riches" Portfolio YTD By A 2-To-1 Margin
Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022. Perhaps some will bounce back with 
Via Talk Markets
6 Largest Psychedelic Stocks Showing Strength; Up 11.5% YTD
A look at the performance of the six largest psychedelic stocks by market capitalization. 
Via Talk Markets
ATAI Life Sciences, GH Research Among Top Psychedelic Movers Of Today
Via Benzinga
Cybin, Compass Pathways Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelic Stock Gainers And Losers From February 15, 2023
Via Benzinga
GH Research, Mind Medicine Among Top Psychedelic Movers Of Today
Via Benzinga
Mind Medicine, GH Research Among Top Psychedelic Movers Of Today
Via Benzinga
"Multi-Bagger" Portfolio Update
Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022. I'm tracking 12 microcap stocks that might bounce back with major returns - dare I say 
Via Talk Markets
Major Psychedelic Compound-Based Stocks UP 13% YTD
We track the performance of the 6 largest companies researching the treatment of mental illnesses based on the use of one or more of 10 different psychedelic compound-based substances. 
Via Talk Markets
Cybin, Seelos Therapeutics Among Top Psychedelic Movers Of Today
Via Benzinga
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelic Stock Gainers And Losers From February 8, 2023
Via Benzinga
Psychedelic Stock Gainers And Losers From February 7, 2023
Via Benzinga
The "Multi-Bagger" Portfolio Continued To Outperform The S&P 500 Last Week
Our basket of mostly microcap cannabis, psychedelic and plant-based food stocks was extremely oversold in 2022 but we're watching for them to bounce back in 2023. 
Via Talk Markets
Mind Medicine, GH Research Among Top Psychedelic Movers Of Today
Via Benzinga
The 7 Most Promising Psychedelic Stocks to Buy in February
These psychedelics stocks to buy belong to pre-revenue firms which could potentially blow-up in line with the burgeoning sector. 
Via InvestorPlace
6 Largest Psychedelic Stocks Down 3% This Week
The six largest of the 40 companies researching the treatment of mental illnesses by using psychedelic substances, which constitute our Psychedelic Drug Stocks Index, are now up 13% YTD despite a loss... 
Via Talk Markets
Psychedelic Stock Gainers And Losers From February 3, 2023
Via Benzinga
'Sea Change': Irwin Naturals, Numinus And Field Trip Discuss Psychedelics At Cantor Webinar
Cantor Fitzgerald's Pablo Zuanic hosted a virtual panel discussion about the psychedelics industry with three ketamine therapy providers: Irwin Naturals (OTCMKTS: IWINF)’ CEO Klee Irwin, Field Trip H&W... 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 2, 2023
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
31 32 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.